These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38931160)

  • 1. Dietary Phosphorus Levels Influence Protein-Derived Uremic Toxin Production in Nephrectomized Male Rats.
    Cladis DP; Burstad KM; Biruete A; Jannasch AH; Cooper BR; Hill Gallant KM
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fecal microbiome and serum concentrations of indoxyl sulfate and p-cresol sulfate in cats with chronic kidney disease.
    Summers SC; Quimby JM; Isaiah A; Suchodolski JS; Lunghofer PJ; Gustafson DL
    J Vet Intern Med; 2019 Mar; 33(2):662-669. PubMed ID: 30561098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients?
    Black AP; Anjos JS; Cardozo L; Carmo FL; Dolenga CJ; Nakao LS; de Carvalho Ferreira D; Rosado A; Carraro Eduardo JC; Mafra D
    J Ren Nutr; 2018 May; 28(3):208-214. PubMed ID: 29439931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota and Uremic Retention Solutes in Adults With Moderate CKD: A 6-Day Controlled Feeding Study.
    Wiese GN; Biruete A; Stremke ER; Lindemann SR; Jannasch A; Moorthi RN; Moe SM; Swanson KS; Cross TW; Hill Gallant KM
    J Ren Nutr; 2024 Jan; 34(1):26-34. PubMed ID: 37468049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.
    Rossi M; Johnson DW; Xu H; Carrero JJ; Pascoe E; French C; Campbell KL
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):860-865. PubMed ID: 26026209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Liver in Determining Serum Colon-Derived Uremic Solutes.
    Lin CJ; Liou TC; Pan CF; Wu PC; Sun FJ; Liu HL; Chen HH; Wu CJ
    PLoS One; 2015; 10(8):e0134590. PubMed ID: 26258409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis.
    Iguchi A; Yamamoto S; Oda A; Tanaka K; Kazama JJ; Saeki T; Yamazaki H; Ishioka K; Suzutani T; Narita I
    Clin Exp Nephrol; 2020 Aug; 24(8):725-733. PubMed ID: 32285213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
    Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
    Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum indoxyl sulfate concentrations associate with progression of chronic kidney disease in children.
    Holle J; Kirchner M; Okun J; Bayazit AK; Obrycki L; Canpolat N; Bulut IK; Azukaitis K; Duzova A; Ranchin B; Shroff R; Candan C; Oh J; Klaus G; Lugani F; Gimpel C; Büscher R; Yilmaz A; Baskin E; Erdogan H; Zaloszyc A; Özcelik G; Drozdz D; Jankauskiene A; Nobili F; Melk A; Querfeld U; Schaefer F;
    PLoS One; 2020; 15(10):e0240446. PubMed ID: 33108385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
    Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
    Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Changes Involving Bifidobacterium longum and Other Nutrients Delays Chronic Kidney Disease Progression.
    Iwashita Y; Ohya M; Yashiro M; Sonou T; Kawakami K; Nakashima Y; Yano T; Iwashita Y; Mima T; Negi S; Kubo K; Tomoda K; Odamaki T; Shigematsu T
    Am J Nephrol; 2018; 47(5):325-332. PubMed ID: 29779028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
    Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
    Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prebiotic oligofructose-enriched inulin on gut-derived uremic toxins and disease progression in rats with adenine-induced chronic kidney disease.
    Melekoglu E; Cetinkaya MA; Kepekci-Tekkeli SE; Kul O; Samur G
    PLoS One; 2021; 16(10):e0258145. PubMed ID: 34614017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.
    Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W
    Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.
    Kikuchi M; Ueno M; Itoh Y; Suda W; Hattori M
    Nephron; 2017; 135(1):51-60. PubMed ID: 27701177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emodin via colonic irrigation modulates gut microbiota and reduces uremic toxins in rats with chronic kidney disease.
    Zeng YQ; Dai Z; Lu F; Lu Z; Liu X; Chen C; Qu P; Li D; Hua Z; Qu Y; Zou C
    Oncotarget; 2016 Apr; 7(14):17468-78. PubMed ID: 27003359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).
    Rocchetti MT; Cosola C; di Bari I; Magnani S; Galleggiante V; Scandiffio L; Dalfino G; Netti GS; Atti M; Corciulo R; Gesualdo L
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.